1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)


Table 2: 
Categories and timing of PRES neurotoxicity
Toxicity CategoryNo. of PatientsSubgroupNo. of PatientsTime Point of PRES Relative to ‘Association’ Event
0–1 mos (# pts)1–4 mos (# pts)4–12 mos (# pts)> 12 mos (# pts)Not Known (# pts)
Cyclosporine/FK-506 toxicity49allo-BMT2616541
SOT205357
CsA only33
Postchemotherapy4431
Infection/sepsis/shock25Infection/Sepsis232111
Hemorrhagic Shock22
Eclampsia11Intrapartum33
Delayed88
Autoimmune111111
Miscellaneous666
Total10610656109823
  • Note:—# pts indicates number of patients; mos, months; SOT, solid organ transplant; CsA only, cyclosporine treatment in marrow diseases; PRES, posterior reversible encephalopathy syndrome; allo-BMT, allogenic bone marrow transplantation.